Share This

Public company info - Real Nutriceutical Group Ltd. , 02010.HK

Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Real Nutriceutical Group Ltd., 02010.HK - Cash Flow 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12 2008-12 2007-12 2006-12
Net Cash Flow from Operating Activities 44,562 277,831 901,935 863,519 819,026 575,645 639,322 686,854 313,332 -49,291 16,733 59,934
Net Cash Flow from Return on Investments & Servicing of Finance 6,388 -44,416 -65,172 -49,886 -36,503 -24,702 -31,355 -25,777 -11,461 -12,737 -152,133 -9,791
 Interest Received 43,074 40,053 58,765 54,394 40,032 46,206 25,670 3,038 430 1,524 5,326 3,789
 Interest Paid -36,686 -28,191 -52,693 -46,633 -25,666 -23,425 -19,484 -10,582 -11,891 -14,261 -18,846 -13,580
 Dividend Received 0 0 0 0 0 0 0 0 0 0 0 0
 Dividend Paid 0 -56,278 -71,244 -57,647 -50,869 -47,483 -37,541 -18,233 0 0 -138,613 0
 Others 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -33,977 -95,279 -230,356 -216,396 -195,821 -227,260 -214,760 -150,684 -78,819 -29,217 -4,410 -2,932
Net Cash Flow from Investing Activities -197,307 -325,124 -438,870 -736,078 -657,898 -444,814 -507,337 -285,188 -81,244 -129,843 248,088 -278,628
 Additions to Fixed Assets -7,649 -149,047 -438,610 -465,952 -562,041 -401,295 -346,517 -211,897 -71,559 -121,961 -12,036 -89,438
 Disposal of Fixed Assets 21 296 0 3,732 0 0 0 0 0 0 77 92
 Increase in Investments 0 0 0 -199,617 0 0 0 0 2,295 0 0 0
 Decrease in Investments 10,321 0 0 0 0 0 0 0 0 0 0 0
 Net Cash Flow with Related Parties 0 0 40,000 -100,000 0 0 0 -51,728 51,558 -79,831 -47,691 147,487
 Others -200,000 -176,373 -40,260 25,759 -95,857 -43,519 -160,820 -21,563 -63,538 71,949 307,738 -336,769
Net Cash Flow before Financing Activities -180,334 -186,988 167,537 -138,841 -71,196 -121,131 -114,130 225,205 141,808 -221,088 108,278 -231,417
Net Cash Flow from Financing Activities 22,638 267,642 397,890 386,563 397,246 66,107 35,086 1,021,012 71,558 105,142 -12,857 242,846
 New Loans 740,840 814,190 636,133 1,025,000 568,000 670,000 655,000 376,000 344,000 269,000 302,285 357,500
 Loans Repayment -718,202 -541,920 -1,028,133 -582,000 -328,000 -602,000 -593,000 -537,000 -324,000 -266,021 -417,005 -262,149
 Fixed Income/Debt Instruments 0 0 0 0 157,246 0 0 0 0 0 0 0
 Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0
 Equity Financing 0 0 90,003 43,563 0 0 0 1,233,740 0 181,994 149,554 8
 Net Cash Flow with Related Parties 0 0 40,000 -100,000 0 0 0 -51,728 51,558 -79,831 -47,691 147,487
 Others 0 -4,628 659,887 0 0 -1,893 -26,914 0 0 0 0 0
Increase(Decrease) in Cash & Cash Equivalents -157,696 80,654 565,427 247,722 326,050 -55,024 -79,044 1,246,217 213,366 -115,946 95,421 11,429
Cash & Cash Equivalents at Beginning of Year 2,554,938 2,477,308 1,904,033 1,656,434 1,329,295 1,384,327 1,462,045 215,216 1,840 117,768 22,347 10,918
Net Cash Flow due to Change in Exchange Rate/Others 3,232 -3,024 7,848 -123 1,089 -8 1,326 612 10 18 0 0
Cash & Cash Equivalents at End of Year 2,400,474 2,554,938 2,477,308 1,904,033 1,656,434 1,329,295 1,384,327 1,462,045 215,216 1,840 117,768 22,347
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit Thousand Thousand Thousand Thousand Thousand Thousand
Auditor's Opinion 1 1 1 1 1 1 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.